Chiltern Opens New Office in Argentina
LONDON, Feb. 17 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in Argentina.
Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor. "Our office, strategically located in suburban Pilar, is a natural next step to our development in Argentina. The office's state-of-the-art facilities and technology are designed to support our growing client needs in Mexico, Chile, Peru and throughout all Latin America, complementing Chiltern's Sao Paulo, Brazil office," commented Oscar.
"Chiltern's opening of the Buenos Aires office in 2010 continues our globalization effort following the opening of four new offices in 2009," stated Glenn Kerkhof, Chiltern CEO. "Chiltern's strong presence in Argentina, Brazil, Mexico and the entire Latin American region demonstrates our commitment to providing high quality services globally."
The Argentina office is located at:
Colectora Panamericana Ramal Pilar km 53,5
Edificio Polo Uno; 209/207
Pilar, Buenos Aires, Argentina 1629
Phone: +54 2322 374 020 Fax: +54 2322 668 594
Established in 1982, Chiltern is a leading global clinical Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 23 offices within 16 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information is available at www.chiltern.com.
For More Information Contact:
Chiltern International Ltd.
Chiltern International Inc.
171 Bath Road
1241 Volunteer Parkway
Berkshire SL1 4AA
Bristol, TN 37620
Tel: +44 (0) 1753 512 000
Tel: +1 (423) 968 9533
Fax: +44 (0) 1753 511 116
Fax: +1 (423) 968 3567
More by this Source
Chiltern Appoints Andrew Monaghan, PhD, Director, Global Pharmacovigilance
Jul 24, 2013, 02:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.